510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K103676Substantially Equivalent

Fujirebio Diagnostics Tumor Marker Control

Fujirebio Diagnostics, Inc., Malvern PA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K103676 is the FDA 510(k) clearance record for FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROL, a class II device, cleared for Fujirebio Diagnostics,Inc. on under FDA product code OIU (Test, Epithelial Ovarian Tumor Associated Antigen (He4)). FDA's definition for product code OIU reads: "An enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient...". FDA records list 45 510(k) clearances for Fujirebio Diagnostics,Inc., from to . As of , FDA records show no recalls naming K103676.

Clearance record

Decision date
Received
(215 days to decision)
Product code
OIU Test, Epithelial Ovarian Tumor Associated Antigen (He4)
Regulation
21 CFR 866.6010
Device class
Class II
Review panel
Immunology
Applicant
Fujirebio Diagnostics,Inc. 201 Great Valley Pkwy., Malvern PA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code OIU

Trailing 12 months

FDA records hold no clearances under product code OIU in the trailing twelve months.

FDA records show no clearances under product code OIU in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code OIU, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260